AxoGen, Inc. Announces Release Date of 2012 Fourth Quarter & Year End Results and Conference Call

Published: Feb 27, 2013

AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that it will release its financial results for the period ended December 31, 2012, after the close of U.S. financial markets on March 12, 2013.

Back to news